 I hope I'm saying that somewhat correct, but move that into clinical trials later this year. The company said on Thursday after scrapping a twice-daily version of the drug late last year. The new drug is part of the second generation of weight loss pills under development by companies including Eli Lilly and Novo Nordisk that will offer patients a more convenient alternative drug.